Biomarkers of renal cell carcinoma - Past and future considerations

Author： de la Taille A.   Buttyan R.   Katz A.E.   McKiernan J.   Burchardt M.   Burchardt T.   Chopin D.K.   Sawczuk I.S.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.5, Iss.4, 2000-07, pp. : 139-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma

By Gibson Todd   Weinstein Stephanie   Mayne Susan   Pfeiffer Ruth   Selhub Jacob   Taylor Philip   Virtamo Jarmo   Albanes Demetrius   Stolzenberg-Solomon Rachael  

Cancer Causes and Control, Vol. 21, Iss. 7, 2010-07 ,pp. : 1061-1069

Springer Publishing Company

Access to resources Recommend Favorite

Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 3, 2010-03 ,pp. : 225-235

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy of renal cell carcinoma

By Gouttefangeas Cécile   Stenzl Arnulf   Stevanović Stefan   Rammensee Hans-Georg  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 117-128

Springer Publishing Company

Access to resources Recommend Favorite

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

By Santoni Matteo   De Tursi Michele   Felici Alessandra   Lo Re Giovanni   Ricotta Riccardo   Ruggeri Enzo Maria   Sabbatini Roberto   Santini Daniele   Vaccaro Vanja   Milella Michele  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 697-709

Informa Healthcare

Access to resources Recommend Favorite

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

By Pal Sumanta  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 5-16

Springer Publishing Company

Access to resources Recommend Favorite